A presentation to: Meeting name Date

Slides:



Advertisements
Similar presentations
Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema: Potential impact of.
Advertisements

Journal Club 1 The bigger picture. How we hope it works – Introduction – Discussion Points – Summary.
The Bahrain Branch of the UK Cochrane Centre In Collaboration with Reyada Training & Management Consultancy, Dubai-UAE Cochrane Collaboration and Systematic.
The Diabetic Retinopathy Clinical Research Network
Systematic Reviews.
Evidence Based Medication Use in the NICU: Erythropoietin Dan Ellsbury MD Director, Continuous Quality Improvement Pediatrix Medical Group.
Retinitis Pigmentosa Paulette Frank, Amy Hayes, Monica Johnson, and Michelle Parker.
Effects of a combination of varenicline and nicotine patch on post-quitting urges to smoke Katie Myers Smith BSc MSc CPsychol Research Fellow Wolfson Institute.
The AMBER study Abdominal Massage for Neurogenic Bowel Dysfunction in People with Multiple Sclerosis Background Objective Study Design and AMBER Study.
Applying CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage 2) in a Pre- Hospital Wilderness Context Paul B. Jones PGY1.
Vaccines for preventing influenza in healthy adults: a Cochrane review Clinical
The Diabetic Retinopathy Clinical Research Network DRCR.net Prompt PRP vs Ranibizumab+Deferred PRP for PDR Study Jeffrey G. Gross, M.D. – Protocol Chair.
Selenium supplementation for the primary prevention of cardiovascular disease: a Cochrane review Clinical
The Diabetic Retinopathy Clinical Research Network
Summary of “A randomized trial of standard versus intensive blood-pressure control” The SPRINT Research Group, NEJM, DOI: /NEJMoa Downloaded.
Psychosocial Combined with Agonist Maintenance Treatments versus Agonist Maintenance Treatments Alone for Treatment of Opioid Dependence (Review) Amato,
The Diabetic Retinopathy Clinical Research Network
METHODS and STATISTICS
The Diabetic Retinopathy Clinical Research Network
Invest. Ophthalmol. Vis. Sci ;43(9): Figure Legend:
A presentation to: Meeting name Date
The Diabetic Retinopathy Clinical Research Network
A presentation to: Meeting name Date
A presentation to: Meeting name Date
nAMD: Choosing the Best Treatment for your Patient
A presentation to: Meeting name Date
A presentation to: Meeting name Date
Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:
Randomized Clinical Trial Jeffrey G. Gross, M.D. for the DRCR Network
JAMA Ophthalmology Journal Club Slides: Effect of Oral Voriconazole on Fungal Keratitis Prajna NV, TKrishnan T, Rajaraman R, et al; Mycotic Ulcer Treatment.
Omega-3 Prescriptions vs Supplements in Practice
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
The Diabetic Retinopathy Clinical Research Network
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
nAMD: Choosing the Best Treatment for your Patient
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
pulmonary embolism protocol -- EMB review
A presentation to: Meeting name Date
A presentation to: Meeting name Date
A presentation to: Meeting name Date
DEFINITION OF BLINDNESS- REVIEW
A presentation to: Meeting name Date
Omega-3s vs Pure EPA in Clinical Practice
DRCR Retina Network Treatment for Center-Involved DME in Eyes with Good Visual Acuity (Protocol V)
Translating Data From Trial to Practice
Yoga treatment for chronic non-specific low back pain
Presentation transcript:

A presentation to: Meeting name Date Vitamin A and fish oils for retinitis pigmentosa Sobharani Rayapudi, Stephen G Schwartz, Xue Wang, Pamela Chavis Issue 12, 2013 A presentation to: Meeting name Date

Table of Contents 01 Background 02 Types of studies 03 Key results 04 Tables (Risk of Bias/Forest Plots) 05 Conclusions 06 Acknowledgements

01: Background Retinitis pigmentosa (RP) classifies a group of eye diseases that cause degeneration of the retinal photoreceptors Symptoms can start at any age There is no proven therapy to treat RP OBJECTIVE: To synthesize evidence for the effectiveness and safety of Vitamin A and fish oils in preventing the progression of RP

02: Types of studies Participants 866 participants, three RCTs Interventions Vitamin A alone Fish oil alone Vitamin A + Fish oil vs Vitamin A alone

03: Key results “The primary outcome, mean change of visual field from baseline at one year, was not reported in any of the studies.” “No toxicity or adverse events were reported in these three trials.” “No trial reported a statistically significant benefit of vitamin supplementation on the progression of visual field loss or visual acuity loss.”

03: Key results (continued) “Two of the three trials reported statistically significant differences in ERG amplitudes among some subgroups of participants, but these results have not been replicated or substantiated by findings in any of the other trials.”

04: Tables

05: Conclusions “Based on the results of three RCTs, there is no clear evidence for benefit of treatment with vitamin A and/or DHA for people with RP, in terms of the mean change in visual field and ERG amplitudes at one year and the mean change in visual acuity at five years follow-up. ”

06: Acknowledgements Cochrane Eyes and Vision US Satellite, funded by the National Eye Institute, National Institutes of Health Cochrane Eyes and Vision Editorial Base, funded by the UK National Health Service Research and Development Programme Sobharani Rayapudi, Stephen G Schwartz, Xue Wang, Pamela Chavis Review citation Rayapudi S, Schwartz SG, Wang X, Chavis P. Vitamin A and fish oils for retinitis pigmentosa. Cochrane Database of Systematic Reviews 2013, Issue 12. Art. No.: CD008428. DOI: 10.1002/14651858.CD008428.pub2